Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Aesthetic Medical International Holdings Group Equity-to-Asset?
Aesthetic Medical International Holdings GroupFRA:3FMA Equity-to-Asset is -0.04 as of Dec. 2025. The stock has 5 warning signs investors should review. Among 684 Healthcare Providers & Services companies, Aesthetic Medical International Holdings Group ranks worse than 91.23% on this metric.
FRA:3FMA's Equity-to-Asset is ranked worse than 91.23% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 0.49
vs FRA:3FMA: -0.04
Aesthetic Medical International Holdings Group (FRA:3FMA) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Aesthetic Medical International Holdings Group Equity-to-Asset Related Terms
Aesthetic Medical International Holdings Group Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aesthetic Medical International Holdings Group Equity-to-Asset Chart
Aesthetic Medical International Holdings Group Annual Data
FRA:3FMA vs GRST, FCHS, FOXO: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Aesthetic Medical International Holdings Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aesthetic Medical International Holdings Group Equity-to-Asset vs Healthcare Providers & Services Industry
Aesthetic Medical International Holdings Group Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aesthetic Medical International Holdings Group (FRA:3FMA) has a Equity-to-Asset of -0.04 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Aesthetic Medical International Holdings Group and its competitors. According to the industry distribution chart, Aesthetic Medical International Holdings Group ranks #624 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 91.2%.
Is Aesthetic Medical International Holdings Group's Equity-to-Asset too high?
Aesthetic Medical International Holdings Group's current Equity-to-Asset is -0.04. Based on the distribution chart, Aesthetic Medical International Holdings Group ranks #624 out of 684 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Aesthetic Medical International Holdings Group's Equity-to-Asset compare to GRST and FCHS?
According to the Healthcare Providers & Services industry distribution chart, Aesthetic Medical International Holdings Group ranks #624 out of 684 companies for Equity-to-Asset. This places Aesthetic Medical International Holdings Group in the lower half of its industry. The industry median Equity-to-Asset is 0.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Aesthetic Medical International Holdings Group and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aesthetic Medical International Holdings Group's current Equity-to-Asset is -0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aesthetic Medical International Holdings Group stock overvalued right now?
Aesthetic Medical International Holdings Group (FRA:3FMA) has a current Equity-to-Asset of -0.04. The stock's GF Value™ is €0.14, compared to a current price of €0.01 — trading 93.6% below its estimated fair value. The current Equity-to-Asset is -0.04. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Aesthetic Medical International Holdings Group (FRA:3FMA), the current Equity-to-Asset is -0.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aesthetic Medical International Holdings Group Ltd provides aesthetic medical services in China. The company generates revenue from three service offerings: non-surgical aesthetic medical services, surgical aesthetic medical services, general healthcare services, and other aesthetic medical services in the People's Republic of China. The company derives a majority of its revenue from Non-surgical aesthetic medical services. Geographically, it derives revenue from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3FMA has been successfully added to your 
